» Articles » PMID: 17574511

Minimal Cardiopulmonary Bypass Attenuates Neutrophil Activation and Cytokine Release in Coronary Artery Bypass Grafting

Overview
Journal J Artif Organs
Date 2007 Jun 19
PMID 17574511
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The minimal cardiopulmonary bypass (mini-CPB) circuit, a closed system with neither cardiotomy suction nor an open venous reservoir and thus no air-blood interface, reportedly reduces blood loss and inflammatory reactions associated with coronary bypass surgery. We evaluated the inflammatory reactions in patients in whom coronary bypass operations were performed with conventional CPB or mini-CPB (n=15 each). Interleukin (IL)-6, IL-8, and neutrophil elastase levels; the neutrophil count; and the C-reactive protein value were measured before and immediately after surgery and on postoperative days 1 and 2. In addition, intraoperative blood loss and the transfusion volume were evaluated in these groups. Neutrophil elastase levels were lower in the mini-CPB group than in the conventional group on postoperative days 1 (127 +/- 52 vs. 240 +/- 100 microg/l, P=0.013) and 2 (107 +/- 17 vs. 170 +/- 45 micro/l, P=0.0001), as was the IL-8 level on postoperative day 1 (8.3 +/- 6.4 vs. 19 +/- 11 pg/ml, P=0.016). The intraoperative blood loss and transfusion volumes were significantly lower in the mini-CPB group than in the conventional group (510 +/- 244 vs. 1046 +/- 966 ml, P=0.012, and 691 +/- 427 vs. 1416 +/- 918 ml, P=0.0033). Thus, mini-CPB appears to attenuate neutrophil activation and cytokine release after coronary bypass surgery and, in addition, has some beneficial effects on blood conservation.

Citing Articles

Effects of interventions targeting the systemic inflammatory response to cardiac surgery on clinical outcomes in adults.

Abbasciano R, Tomassini S, Roman M, Rizzello A, Pathak S, Ramzi J Cochrane Database Syst Rev. 2023; 10:CD013584.

PMID: 37873947 PMC: 10594589. DOI: 10.1002/14651858.CD013584.pub2.


Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up.

Sardu C, Massetti M, Testa N, Di Martino L, Castellano G, Turriziani F Front Pharmacol. 2021; 12:777083.

PMID: 34867407 PMC: 8634684. DOI: 10.3389/fphar.2021.777083.


Inflammation and coagulation following minimally invasive extracorporeal circulation technologies.

Ranucci M, Baryshnikova E J Thorac Dis. 2019; 11(Suppl 10):S1480-S1488.

PMID: 31293797 PMC: 6586586. DOI: 10.21037/jtd.2019.01.27.


Effects of Minimal Extracorporeal Circulation on the Systemic Inflammatory Response and the Need for Transfusion after Coronary Bypass Grafting Surgery.

Elci M, Kahraman A, Mutlu E, Ispir C Cardiol Res Pract. 2019; 2019:1726150.

PMID: 31275639 PMC: 6589289. DOI: 10.1155/2019/1726150.


MnSOD, CAT and GPx-3 genetic polymorphisms in coronary artery disease.

Dogan A, Ozsensoy Y, Turker F Mol Biol Rep. 2019; 46(1):841-845.

PMID: 30600457 DOI: 10.1007/s11033-018-4539-3.


References
1.
Remadi J, Marticho P, Butoi I, Rakotoarivelo Z, Trojette F, Benamar A . Clinical experience with the mini-extracorporeal circulation system: an evolution or a revolution?. Ann Thorac Surg. 2004; 77(6):2172-5. DOI: 10.1016/S0003-4975(03)00977-9. View

2.
Wiesenack C, Liebold A, Philipp A, Ritzka M, Koppenberg J, Birnbaum D . Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs. 2004; 28(12):1082-8. DOI: 10.1111/j.1525-1594.2004.00030.x. View

3.
Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt M, Deleuze P . Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg. 2002; 22(4):527-33. DOI: 10.1016/s1010-7940(02)00372-x. View

4.
Frering B, Philip I, Dehoux M, Rolland C, Langlois J, Desmonts J . Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1994; 108(4):636-41. View

5.
Kunkel S, Standiford T, Kasahara K, Strieter R . Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res. 1991; 17(1):17-23. DOI: 10.3109/01902149109063278. View